Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lacave

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Cancer Treatment Reports|May 1, 1979
Iron toxicity studies of quelamycinA Brugarolas, J A Perez Llanderal, M T Garcia Miralles, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancerH Bleiberg, T Conroy, B Paillot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 29, 2003
Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapyE Esteban, L González de Sande, Y Fernández, et al.
Breast Cancer Research and Treatment|October 4, 2000
A phase II trial of cyclophosphamide, epirubicin and vinorelbine in the treatment of advanced breast cancerE Esteban, G de Sande, J Puertas, et al.
Breast Cancer Research and Treatment|September 25, 2003
Combination of docetaxel, epirubicin and vinorelbine administered every 2 weeks as first-line therapy in patients with metastatic breast cancer: a dose-finding studyEmilio Esteban, Antonio Modollel, Luis González de Sande, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1991
Combination chemotherapy with cisplatin and 5-fluorouracil 5-day infusion in the therapy of advanced gastric cancer: a phase II trialA J Lacave, F J Barón, L M Antón, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 26, 2011
Pegylated liposomal doxorubicin and gemcitabine in a fixed dose rate infusion for the treatment of patients with poor prognosis of recurrent ovarian cancer: a phase Ib studyGuillermo Crespo, Marta Sierra, Raquel Losa, et al.
Investigational New Drugs|October 31, 2003
Activity of weekly irinotecan (CPT-11) in patients with advanced non-small cell lung cancer pretreated with platinum and taxanesRosa Sánchez, Emilio Esteban, Isabel Palacio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II studyG J Creemers, G Bolis, M Gore, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 17, 2010
Impact of the incorporation of tyrosine kinase inhibitor agents on the treatment of patients with a diagnosis of advanced renal cell carcinoma: study based on experience at the Hospital Universitario Central de AsturiasCarolina Muriel, Emilio Esteban, Norberto Corral, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Cancer Treatment Reports|May 1, 1979
Iron toxicity studies of quelamycinA Brugarolas, J A Perez Llanderal, M T Garcia Miralles, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancerH Bleiberg, T Conroy, B Paillot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 29, 2003
Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapyE Esteban, L González de Sande, Y Fernández, et al.
Breast Cancer Research and Treatment|October 4, 2000
A phase II trial of cyclophosphamide, epirubicin and vinorelbine in the treatment of advanced breast cancerE Esteban, G de Sande, J Puertas, et al.
Breast Cancer Research and Treatment|September 25, 2003
Combination of docetaxel, epirubicin and vinorelbine administered every 2 weeks as first-line therapy in patients with metastatic breast cancer: a dose-finding studyEmilio Esteban, Antonio Modollel, Luis González de Sande, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1991
Combination chemotherapy with cisplatin and 5-fluorouracil 5-day infusion in the therapy of advanced gastric cancer: a phase II trialA J Lacave, F J Barón, L M Antón, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 26, 2011
Pegylated liposomal doxorubicin and gemcitabine in a fixed dose rate infusion for the treatment of patients with poor prognosis of recurrent ovarian cancer: a phase Ib studyGuillermo Crespo, Marta Sierra, Raquel Losa, et al.
Investigational New Drugs|October 31, 2003
Activity of weekly irinotecan (CPT-11) in patients with advanced non-small cell lung cancer pretreated with platinum and taxanesRosa Sánchez, Emilio Esteban, Isabel Palacio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II studyG J Creemers, G Bolis, M Gore, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 17, 2010
Impact of the incorporation of tyrosine kinase inhibitor agents on the treatment of patients with a diagnosis of advanced renal cell carcinoma: study based on experience at the Hospital Universitario Central de AsturiasCarolina Muriel, Emilio Esteban, Norberto Corral, et al.
Pageof 7